November: Polygenic risk scores (PRS) can be an important tool in breast cancer patients to help stratify individuals into levels of disease risk. The clinical utility of PRS is still being evaluated, but what hasn't yet been evaluated is how to communicate such results to patients, and how they respond to their PRS scores.

September: Team of experts creates ACMG’s first evidence-based clinical guideline recommending exome or genome sequencing for pediatric patients with congenital anomalies or intellectual disability

August: Diagnosing the undiagnosed: Genetic testing identifies the underlying causes of kidney disease

July: Artificial intelligence may provide a timely diagnosis for Fragile X syndrome

June: Universal newborn screening to identify pediatric cancer predisposition – could it work?

May: The implementation of clinical genomic DNA methylation testing in patients with rare disorders

April: Increasing access to genomic medicine in diverse communities: What shapes Latinx perspectives on health care incorporating genomics?

March: Turning principles into policy: Combating systemic racism in genetics and genomics publications

February: Targeted exome sequencing for second-tier newborn screening tests: technology to scale

January: Is newborn screening for metachromatic leukodystrophy coming soon?